Curaleaf Holdings Inc
TSX:CURA
Intrinsic Value
Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. [ Read More ]
The intrinsic value of one
CURA
stock under the Base Case scenario is
8.67
CAD.
Compared to the current market price of 7.35 CAD,
Curaleaf Holdings Inc
is
Undervalued by 15%.
Curaleaf Holdings Inc's market capitalization is 4.7B CAD.
CURA stock price is 7.35 CAD.
CURA stock price (7.35 CAD) is 15% less than its Intrinsic Value (8.67 CAD).
CURA has upside potential of 45% compared to the average analyst price target.
Open Wall St Estimates
CURA has positive three-year average ROIC (Return on Invested Capital): 10%. The company is efficient at using invested capital to generate operating income.
CURA's Revenue has grown by 6% over the past 12 months.
CURA's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 3%.
CURA's ROIC (Return on Invested Capital) has decreased in the last 3 years from 11% to 3%.
CURA's D/E (Debt to Equity) is very low and is equal to 0.87.
CURA's Revenue is forecast to grow at a rate of 15% per year over the next 3 years.
CURA's short-term liabilties (494m USD) exceed its short-term assets (419m USD).
CURA's long-term assets (3B USD) exceed its long-term liabilties (2B USD).
CURA has positive Gross Profit for the last twelve months.
CURA's ROE (Return on Equity) has significantly decreased in the last 3 years from -5% to -24%, and is approaching profitability.
CURA's Revenue has been growing by an exceptional 29% per year for the last 3 years.
CURA has positive Operating Income for the last twelve months.
CURA has negative Net Income for the last twelve months.
CURA's ROE (Return on Equity) for the past 12 months is negative and is equal to -24%.
CURA has positive Free Cash Flow for the last twelve months.
CURA has positive Net Debt. This means that the company has more debt (917m USD) than cash and short-term investments (92m USD).
CURA's Altman Z-Score is very low and is equal to 0.94.
CURA has negative three-year average ROE (Return on Equity): -17%. The company is not efficient at transforming stockholders' equity into net income.
CURA doesn't generate enough operating income (43m USD) to safely cover interest payments on its debt (98m USD).
Valuation Backtest
Curaleaf Holdings Inc
Run backtest to discover the historical profit from buying and selling
CURA
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Curaleaf Holdings Inc
Balance Sheet Decomposition
Curaleaf Holdings Inc
| Current Assets | 418.6m |
| Cash & Short-Term Investments | 91.8m |
| Receivables | 62.7m |
| Other Current Assets | 264.1m |
| Non-Current Assets | 2.7B |
| Long-Term Investments | 2.5m |
| PP&E | 833.3m |
| Intangibles | 1.8B |
| Other Non-Current Assets | 43.2m |
| Current Liabilities | 494m |
| Accounts Payable | 79.3m |
| Accrued Liabilities | 117.3m |
| Other Current Liabilities | 297.4m |
| Non-Current Liabilities | 1.6B |
| Long-Term Debt | 917.1m |
| Other Non-Current Liabilities | 634.8m |
Earnings Waterfall
Curaleaf Holdings Inc
|
Revenue
|
1.3B
USD
|
|
Cost of Revenue
|
-732.2m
USD
|
|
Gross Profit
|
614.4m
USD
|
|
Operating Expenses
|
-571.6m
USD
|
|
Operating Income
|
42.9m
USD
|
|
Other Expenses
|
-324.1m
USD
|
|
Net Income
|
-281.2m
USD
|
Free Cash Flow Analysis
Curaleaf Holdings Inc
CURA Profitability Score
Profitability Due Diligence
Curaleaf Holdings Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
Score
Curaleaf Holdings Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
CURA Solvency Score
Solvency Due Diligence
Curaleaf Holdings Inc's solvency score is 27/100. The higher the solvency score, the more solvent the company is.
Score
Curaleaf Holdings Inc's solvency score is 27/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CURA Price Targets Summary
Curaleaf Holdings Inc
According to Wall Street analysts, the average 1-year price target for
CURA
is 10.63 CAD
with a low forecast of 6.57 CAD and a high forecast of 24.57 CAD.
Shareholder Return
CURA Price
Curaleaf Holdings Inc
| Average Annual Return | -45.73% |
| Standard Deviation of Annual Returns | 6.04% |
| Max Drawdown | -83% |
| Market Capitalization | 4.7B CAD |
| Shares Outstanding | 642 543 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Curaleaf Holdings Inc
Country
Industry
Market Cap
Dividend Yield
Description
Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. The company is headquartered in New York City, New York and currently employs 5,931 full-time employees. The company went IPO on 2015-10-22. The firm and its brands, including Curaleaf, Select, and Grassroots provide service, product selection and accessibility across the medical and adult-use markets. The company operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York, and Pennsylvania. Curaleaf International is the vertically integrated cannabis company in Europe with a supply and distribution network throughout the European market, bringing together science and research with cultivation, extraction and production. Curaleaf is the national retail dispensary brand in the United States and a mainstream cannabis brand available in multiple states and product formats: vape oils and concentrates, flower, pre rolls and flower pod, topical lotions, capsules and tinctures, mints and lozenges and edibles.
Contact
IPO
Employees
Officers
The intrinsic value of one
CURA
stock under the Base Case scenario is
8.67
CAD.
Compared to the current market price of 7.35 CAD,
Curaleaf Holdings Inc
is
Undervalued by 15%.
You don't have any saved screeners yet
